{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"21"}],"units":"Participants"}],"description":"Responder is defined as subject with a decrease greater than or equal to 5mm Hg in diastolic blood pressure from baseline to week 24 or last visit.","groups":[{"description":"Mifepristone was administered at doses of 300-1200 mg daily.","id":"OG000","title":"Mifepristone"}],"paramType":"NUMBER","reportingStatus":"POSTED","timeFrame":"Baseline to Week 24","title":"Decrease in Diastolic Blood Pressure.","type":"PRIMARY","unitOfMeasure":"participants"}